Association of Psoriasis with Risk of COVID-19: A 2-Sample Mendelian Randomization Study

Xiaoyu Gu,Xiang Chen,Minxue Shen

DOI: https://doi.org/10.1016/j.jaad.2022.01.048

IF: 15.487

2022-01-01

Journal of the American Academy of Dermatology

Abstract:With the growing pandemic of COVID-19, psoriasis has been reported to be linked with COVID-19 from genetic and epidemiological perspectives, especially in patients receiving systemic treatments.1Patrick M.T. Zhang H. Wasikowski R. et al.Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies.J Allergy Clin Immunol. 2021; 147: 857-869.e7Abstract Full Text Full Text PDF PubMed Scopus (40) Google Scholar, 2Kridin K. Schonmann Y. Tzur Bitan D. et al.Coronavirus disease 2019 (COVID-19)-associated hospitalization and mortality in patients with psoriasis: a population-based study.Am J Clin Dermatol. 2021; 22: 709-718Crossref PubMed Scopus (13) Google Scholar, 3Gisondi P. Bellinato F. Chiricozzi A. Girolomoni G. The risk of COVID-19 pandemic in patients with moderate to severe plaque psoriasis receiving systemic treatments.Vaccines (Basel). 2020; 8: 728Crossref PubMed Scopus (26) Google Scholar However, traditional epidemiology is inevitably affected by confounding bias. Mendelian randomization (MR) is an approach based on genome-wide association studies to construct instrumental variables (IVs) and can effectively control the confounding bias of observational studies. IVs refer to variables that only affect the outcome through risk factors, and MR uses single-nucleotide polymorphisms as IVs to identify risk factors. MR draws on the experiences of randomized trials and uses the Mendelian law of heredity that parental alleles are randomly assigned to the offspring to simulate the causal relationships between exposures and outcomes. Here, we performed a 2-sample MR, in which genetic associations with exposures and outcomes are estimated in different sets of individuals, to investigate the association of psoriasis with COVID-19. We downloaded the summary data from open-access genome-wide association studies data sets at https://gwas.mrcieu.ac.uk/. We used R 4.0.4 and package “TwoSampleMR,” and statistical methods can be found in the guidelines (https://mrcieu.github.io/TwoSampleMR). We used the inverse variance weighted (IVW) method as the primary approach and other algorithms as the supplementary methods. We then tested pleiotropy using MR-Egger regression because valid MR estimations require IVs to be independent of outcomes. Finally, reverse MR and sensitivity analysis were used to test the unidirectionality and robustness of the results, respectively. A P value of <.05 was considered statistically significant. For psoriasis, we extracted the results from the studies by the Neale laboratory, with 3871 cases and 333,288 controls, to generate the IVs (https://gwas.mrcieu.ac.uk/datasets/ukb-a-100/). For COVID-19, the data from the COVID-19 Host Genetics Initiative with 14,134 cases and 1,284,876 controls were gathered as the outcome variables (https://gwas.mrcieu.ac.uk/datasets/ebi-a-GCST010776/).4COVID-19 Host Genetics InitiativeThe COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic.Eur J Hum Genet. 2020; 28: 715-718Crossref PubMed Scopus (447) Google Scholar After removing linkage disequilibrium, 28 single-nucleotide polymorphisms were selected from the exposure datasheet and incorporated into the outcome datasheet. The IVW method, in conjunction with other methods (Fig 1), suggested that the genetic risk of psoriasis was associated with increased susceptibility to COVID-19 (βIVW = 2.94, P = .01). The MR-Egger regression identified no significant horizontal pleiotropy (P = .74). The reverse MR analysis treating COVID-19 as the exposure and psoriasis as the outcome demonstrated an insignificant association (P = .94), indicating the unidirectionality of the relationship. The leave-one-out sensitivity analysis that removed 1 SNP at a time showed stable results, except for rs13196409 (Fig 2).Fig 2Leave-one-out sensitivity analysis of the effect of psoriasis on COVID-19.View Large Image Figure ViewerDownload Hi-res image Download (PPT) Our study revealed a unidirectional effect of psoriasis on COVID-19. By constructing IVs, the associations estimated by the MR analysis have greater accuracy because these estimates are less confounded by socioeconomic, environmental, and behavioral factors, and the timing of causality is reasonable. The finding could be conducive to comprehending the underlying impacts of psoriasis on the phenotype of COVID-19. Previous studies have revealed that patients with psoriasis would probably have an increased risk of developing severe infections; this may be because of the use of immunosuppressants such as methotrexate.5Wakkee M. de Vries E. van den Haak P. Nijsten T. Increased risk of infectious disease requiring hospitalization among patients with psoriasis: a population-based cohort.J Am Acad Dermatol. 2011; 65: 1135-1144Abstract Full Text Full Text PDF PubMed Scopus (99) Google Scholar Future research could concentrate on assessing the effects of systemic drugs such as immunosuppressants on the association of psoriasis with COVID-19. None disclosed.